| Product Code: ETC9950569 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Opioid Receptor Agonist Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Opioid Receptor Agonist Market - Industry Life Cycle |
3.4 United Kingdom (UK) Opioid Receptor Agonist Market - Porter's Five Forces |
3.5 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F |
3.7 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Opioid Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in the UK |
4.2.2 Growing awareness about the benefits of opioid receptor agonists in pain management |
4.2.3 Technological advancements leading to the development of more effective opioid drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment and increasing concerns about opioid abuse |
4.3.2 Growing preference for non-opioid alternatives for pain management |
4.3.3 Potential side effects and risks associated with opioid receptor agonists |
5 United Kingdom (UK) Opioid Receptor Agonist Market Trends |
6 United Kingdom (UK) Opioid Receptor Agonist Market, By Types |
6.1 United Kingdom (UK) Opioid Receptor Agonist Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.4 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.6 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.7 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Opioid Receptor Agonist Market, By Receptor Binding |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F |
6.2.3 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F |
6.3 United Kingdom (UK) Opioid Receptor Agonist Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F |
6.3.3 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.3.4 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F |
6.3.5 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Opioid Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Opioid Receptor Agonist Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Opioid Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 United Kingdom (UK) Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Opioid Receptor Agonist Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Opioid Receptor Agonist Market Export to Major Countries |
7.2 United Kingdom (UK) Opioid Receptor Agonist Market Imports from Major Countries |
8 United Kingdom (UK) Opioid Receptor Agonist Market Key Performance Indicators |
8.1 Number of prescriptions for opioid receptor agonists in the UK |
8.2 Patient satisfaction and reported pain relief from opioid receptor agonist use |
8.3 Research and development investments in new opioid receptor agonist drugs |
9 United Kingdom (UK) Opioid Receptor Agonist Market - Opportunity Assessment |
9.1 United Kingdom (UK) Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 United Kingdom (UK) Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F |
9.3 United Kingdom (UK) Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 United Kingdom (UK) Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United Kingdom (UK) Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 United Kingdom (UK) Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Opioid Receptor Agonist Market - Competitive Landscape |
10.1 United Kingdom (UK) Opioid Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here